Related Experiment Video
Updated: Feb 14, 2026

08:32
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
10.5K
LASP1 in Tumor and Tumor Microenvironment
1Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Tongzipo Road 172, Changsha, Hunan, China.
Current Molecular Medicine
|February 24, 2018
Summary
LIM and SH3 Domain Protein 1 (LASP1) is crucial in cancer progression and metastasis. This review details LASP1's role in tumor biology and its link to the tumor microenvironment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- LIM and SH3 Domain Protein 1 (LASP1) is recognized for its roles in cytoskeleton formation and as a prognostic marker in various cancers.
- LASP1 expression levels correlate with tumor grade, size, and metastatic potential in clinical studies.
- Upregulated LASP1 promotes tumor cell proliferation, migration, and invasion, potentially via cytoskeletal interactions and nuclear translocation.
Purpose of the Study:
- To systematically review the current understanding of LASP1's contribution to physiological and pathological processes, with a focus on cancer.
- To explore the underlying mechanisms and signaling pathways by which LASP1 influences tumorigenesis.
- To provide an overview of LASP1's correlation with the tumor microenvironment.
Main Methods:
- Literature review and systematic summary of existing research on LASP1.
- Analysis of studies investigating LASP1 expression in clinical cancer samples.
- Examination of experimental data on LASP1's functional roles in cancer cell behavior.
Main Results:
- LASP1 is implicated in cytoskeleton organization and cellular processes vital for cancer progression.
- Evidence suggests LASP1's involvement in tumor cell proliferation, migration, and invasion.
- The precise molecular mechanisms and signaling pathways of LASP1 in cancer are still under investigation.
Conclusions:
- LASP1 is a significant factor in cancer development and progression, acting as both a functional protein and a prognostic indicator.
- Further research into LASP1's mechanisms, including its interaction with the tumor microenvironment, is essential for a deeper biological understanding.
- Targeting LASP1 pathways may offer potential therapeutic strategies for cancer treatment.
Related Concept Videos
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Loss of Tumor Suppressor Gene Functions
6.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K

